A major 2026 trend in the UK CRO industry is the normalization of hybrid and decentralized clinical trials (DCTs). In 2026, "Hybrid Trial Models"—which combine traditional site visits with remote monitoring—are identified as the standard expectation for over 70% of new trial designs. This 2026 shift is being powered by the widespread adoption of wearable sensors and "eClinical"...